Sera Prognostics, Inc. (SERA)

NASDAQ: SERA · Real-Time Price · USD
3.540
-0.360 (-9.23%)
At close: Mar 28, 2025, 4:00 PM
3.517
-0.023 (-0.64%)
After-hours: Mar 28, 2025, 7:50 PM EDT
-9.23%
Market Cap 133.33M
Revenue (ttm) 77,000
Net Income (ttm) -32.90M
Shares Out 37.66M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 152,837
Open 3.885
Previous Close 3.900
Day's Range 3.510 - 3.890
52-Week Range 3.520 - 12.360
Beta 0.90
Analysts n/a
Price Target n/a
Earnings Date Mar 19, 2025

About SERA

Sera Prognostics, Inc., a women’s health company, discovers, develops, and commercializes blood-based biomarker tests and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman for the prediction of the expectant mother’s risk of delivering spontaneously. It is also developing a pipeline of novel blood-based biomarker tests for major pregnancy-related conditions, including time-to-birth, predictive analytics product, pregnancy risk prediction pane... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 15, 2021
Employees 57
Stock Exchange NASDAQ
Ticker Symbol SERA
Full Company Profile

Financial Performance

In 2024, Sera Prognostics's revenue was $77,000, a decrease of -74.84% compared to the previous year's $306,000. Losses were -$32.90 million, -9.23% less than in 2023.

Financial Statements

News

Sera Prognostics Inc (SERA) Q4 2024 Earnings Call Transcript

Sera Prognostics Inc (NASDAQ:SERA) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director ...

9 days ago - Seeking Alpha

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

SALT LAKE CITY , March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

9 days ago - PRNewsWire

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS

SALT LAKE CITY , March 19, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

9 days ago - PRNewsWire

Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025

SALT LAKE CITY , March 11, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biom...

17 days ago - PRNewsWire

Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference

SALT LAKE CITY , Feb. 21, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

5 weeks ago - PRNewsWire

Sera Prognostics Announces Pricing of $50 Million Public Offering

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by provi...

6 weeks ago - PRNewsWire

Sera Prognostics Announces Proposed Public Offering

SALT LAKE CITY , Feb. 10, 2025 /PRNewswire/ -- Sera Prognostics, Inc., The Pregnancy Company® ("Sera" or the "Company") (Nasdaq: SERA), which focuses on improving maternal and neonatal health by provi...

6 weeks ago - PRNewsWire

Sera Prognostics to Host Virtual R&D Day on January 31

Event will showcase results of Company's pivotal PRIME study and include the principal investigator SALT LAKE CITY , Jan. 27, 2025 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDA...

2 months ago - PRNewsWire

Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference

SALT LAKE CITY , Jan. 6, 2025 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

2 months ago - PRNewsWire

Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting

SALT LAKE CITY , Dec. 4, 2024 /PRNewswire/ -- Sera Prognostics, Inc. , The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

4 months ago - PRNewsWire

Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference

SALT LAKE CITY , Dec. 2, 2024 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

4 months ago - PRNewsWire

Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SALT LAKE CITY , Nov. 15, 2024 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

4 months ago - PRNewsWire

Sera Prognostics Inc (SERA) Q3 2024 Earnings Call Transcript

Sera Prognostics Inc (NASDAQ:SERA) Q3 2024 Results Conference Call November 7, 2024 5:00 PM ET Company Participants Peter DeNardo - IR Evguenia Lindgardt - President, CEO & Director Austin Aerts - Ch...

5 months ago - Seeking Alpha

SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

SALT LAKE CITY , Nov. 6, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarke...

5 months ago - PRNewsWire

Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024

SALT LAKE CITY , Oct. 28, 2024 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

5 months ago - PRNewsWire

Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference

SALT LAKE CITY , Sept. 4, 2024 /PRNewswire/ --  Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy bioma...

7 months ago - PRNewsWire

Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript

Sera Prognostics, Inc. (NASDAQ:SERA) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners Zhenya Lindgardt - President & CEO Austin Aerts -...

8 months ago - Seeking Alpha

Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024

SALT LAKE CITY , Aug. 8, 2024 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

8 months ago - PRNewsWire

SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

SALT LAKE CITY , Aug. 7, 2024 /PRNewswire/ -- Sera Prognostics Inc. , The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

8 months ago - PRNewsWire

Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024

SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Sera Prognostics  Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomar...

8 months ago - PRNewsWire

Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial

Sera Prognostics Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-Reviewed Journal, Diagnostics SALT LAKE CITY , July 9, 2024 /PRNewswire/ -- Sera Prognostics In...

9 months ago - PRNewsWire

SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION

SALT LAKE CITY , July 1, 2024 /PRNewswire/ --  Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

9 months ago - PRNewsWire

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES

SALT LAKE CITY , May 28, 2024 /PRNewswire/ --  Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomark...

10 months ago - PRNewsWire

Sera Prognostics, Inc. (SERA) Q1 2024 Earnings Call Transcript

Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners Zhenya Lindgardt - President & Chief Executive Offic...

11 months ago - Seeking Alpha

SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

SALT LAKE CITY , May 8, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker...

11 months ago - PRNewsWire